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LETTERS TO THE EDITOR
Antibodies against
macrophages that overlap in
specificity with fibroblasts
To the Editor: In the June issue of Kidney International,
a Technical Note is devoted to the discrimination between
fibroblasts and macrophages in inflamed renal tissue [1].
The authors examined the expression of macrophage
antigens in putative fibroblasts identified by expression
of FSP1. FSP1+ cells expressed macrophage antigens
CD45, Mac-1, Mac-2, Mac-3, CD68, and MHC class II,
but not F4/80. They conclude that among the markers
tested F4/80 is the only one specific for macrophages in
the inflamed mouse kidney since the others are also ex-
pressed in FSP1+ fibroblasts.
We would like to question two assumptions of the
authors.
First, a survey of the literature casts serious doubts on
the specificity of FSP1 (also known as S100A4) for fi-
broblasts. FSP1/S100A4 has been found in various cell
types [2]. Specifically in the kidney, after ureter obstruc-
tion, a fraction of FSP1/S100A4+ cells were identified as
inflammatory cells [3]. In inflamed kidneys we observed
colocalization of FSP1/S100A4 with leukocyte markers in
cells that clearly displayed the morphology of mononu-
clear cells [4].
Second, a subpopulation of dendritic cells expresses
F4/80 [5]. Expression of F4/80 has been demonstrated in
renal dendritic cells [6].
With these facts in mind we propose an interpretation
of the data of Inoue et al [1], which diverge from that of
the authors: At least a fraction of FSP1+ cells in the fi-
brotic kidney are infiltrating leukocytes expressing CD45,
Mac-1, Mac-2, Mac-3, CD68, and MHC class II.
Therefore, the suitability of FSP1 and of F4/80 as mark-
ers for fibroblasts and for macrophages, respectively, must
be questioned.
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Reply from the Authors
We thought our paper in a recent issue of Kidney Inter-
national might stimulate comment on the identification
of macrophages and fibroblasts [1]. Our correspondents
raise two concerns. It is easier to address the second com-
plaint first: our failure to distinguish dendritic cells from
macrophages. This distinction was not our immediate
point. We acknowledge dendritic cells, like macrophages,
have antigen-presenting properties and may be identified
by F4/80 antibodies.
FSP1, or S100A4, is specific for fibroblasts in normal
mice by genetic and protein criteria ([1–3]; reference [7]
in [1]). Our experience in rats is limited, but we have no
reason to feel its specificity is different than mice. Two ex-
periments being readied for publication in human tissue
also support FSP1 specificity in fibroblasts. Nevertheless,
our correspondents’ second criticism cites several publi-
cations that question this specificity.
In one reference, they argue FSP1 is expressed in in-
flammatory cells [3]. Although S100A4 antibody was used
in rat renal tissue, the methods defined stained fibrob-
lasts as “spindle-shaped” cells and stained leukocytes as
“rounded” cells. There was no double-staining to support
this assumption. Some fibroblasts may look ‘round’ de-
pending on their orientation in tissue sections, making a
‘shape’ criterion unreliable.
Our correspondents also assert in their own paper that
FSP1 is expressed by rat leukocytes [4]. Although double-
staining techniques were employed, these authors also
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